机译:核糖体合成的针对伸长因子Tu的硫肽抗生素
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Infectious Diseases Area;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Analytical Sciences;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Global Discovery Chemistry;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Lead Finding Platform;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Infectious Diseases Area;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Expertise Platform Proteases;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland, and Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts 02139 Natural Products Unit;
机译:硫肽的生物合成,具有核糖体合成的前体肽和保守的翻译后修饰
机译:延伸因子Ts和核糖体蛋白L7 / 12的共同结构基序可能与延伸因子Tu相互作用
机译:延伸因子Ts和核糖体蛋白L7 / 12的共同结构母题可能参与与延伸因子Tu的相互作用。
机译:基于精确的质谱基于硫代肽抗生素GE 37468A的肝微粒体代谢的量化和表征
机译:合成 改性聚合物 纳米颗粒 为 生物膜抑制 , 抗生素 封装 , 和 特异性靶向 抗铜绿假单胞菌
机译:硫肽的生物合成具有核糖体合成的前体肽和保守的翻译后修饰
机译:硫肽的生物合成,具有核糖体合成的前体肽和保守的翻译后修饰